1 Ocak 2013 Dergi makalesi Açık Erişim

Jost, N.; Nagy, N.; Corici, C.; Kohajda, Z.; Horvath, A.; Acsai, K.; Biliczki, P.; Levijoki, J.; Pollesello, P.; Koskelainen, T.; Otsomaa, L.; Toth, A.; Papp, J. Gy; Varro, A.; Virag, L.

MARC21 XML

<?xml version='1.0' encoding='UTF-8'?>
<record xmlns="http://www.loc.gov/MARC21/slim">
  <leader>00000nam##2200000uu#4500</leader>
  <datafield tag="700" ind1=" " ind2=" ">
    <subfield code="a">Nagy, N.</subfield>
    <subfield code="u">Univ Szeged, Dept Pharmacol &amp; Pharmacotherapy, Fac Med, H-6720 Szeged, Hungary</subfield>
  </datafield>
  <datafield tag="700" ind1=" " ind2=" ">
    <subfield code="a">Corici, C.</subfield>
    <subfield code="u">Univ Szeged, Dept Pharmacol &amp; Pharmacotherapy, Fac Med, H-6720 Szeged, Hungary</subfield>
  </datafield>
  <datafield tag="700" ind1=" " ind2=" ">
    <subfield code="a">Kohajda, Z.</subfield>
    <subfield code="u">Hungarian Acad Sci, Div Cardiovasc Pharmacol, Szeged, Hungary</subfield>
  </datafield>
  <datafield tag="700" ind1=" " ind2=" ">
    <subfield code="a">Horvath, A.</subfield>
    <subfield code="u">Hungarian Acad Sci, Div Cardiovasc Pharmacol, Szeged, Hungary</subfield>
  </datafield>
  <datafield tag="700" ind1=" " ind2=" ">
    <subfield code="a">Acsai, K.</subfield>
    <subfield code="u">Hungarian Acad Sci, Div Cardiovasc Pharmacol, Szeged, Hungary</subfield>
  </datafield>
  <datafield tag="700" ind1=" " ind2=" ">
    <subfield code="a">Biliczki, P.</subfield>
    <subfield code="u">Univ Szeged, Dept Pharmacol &amp; Pharmacotherapy, Fac Med, H-6720 Szeged, Hungary</subfield>
  </datafield>
  <datafield tag="700" ind1=" " ind2=" ">
    <subfield code="a">Levijoki, J.</subfield>
    <subfield code="u">Orion Pharma, Espoo, Finland</subfield>
  </datafield>
  <datafield tag="700" ind1=" " ind2=" ">
    <subfield code="a">Pollesello, P.</subfield>
    <subfield code="u">Orion Pharma, Espoo, Finland</subfield>
  </datafield>
  <datafield tag="700" ind1=" " ind2=" ">
    <subfield code="a">Koskelainen, T.</subfield>
    <subfield code="u">Orion Pharma, Espoo, Finland</subfield>
  </datafield>
  <datafield tag="700" ind1=" " ind2=" ">
    <subfield code="a">Otsomaa, L.</subfield>
    <subfield code="u">Orion Pharma, Espoo, Finland</subfield>
  </datafield>
  <datafield tag="700" ind1=" " ind2=" ">
    <subfield code="a">Toth, A.</subfield>
    <subfield code="u">Univ Szeged, Dept Pharmacol &amp; Pharmacotherapy, Fac Med, H-6720 Szeged, Hungary</subfield>
  </datafield>
  <datafield tag="700" ind1=" " ind2=" ">
    <subfield code="a">Papp, J. Gy</subfield>
  </datafield>
  <datafield tag="700" ind1=" " ind2=" ">
    <subfield code="a">Varro, A.</subfield>
  </datafield>
  <datafield tag="700" ind1=" " ind2=" ">
    <subfield code="a">Virag, L.</subfield>
  </datafield>
  <datafield tag="909" ind1="C" ind2="4">
    <subfield code="p">BRITISH JOURNAL OF PHARMACOLOGY</subfield>
    <subfield code="v">170</subfield>
    <subfield code="n">4</subfield>
    <subfield code="c">768-778</subfield>
  </datafield>
  <datafield tag="980" ind1=" " ind2=" ">
    <subfield code="a">user-tubitak-destekli-proje-yayinlari</subfield>
  </datafield>
  <datafield tag="540" ind1=" " ind2=" ">
    <subfield code="a">Creative Commons Attribution</subfield>
    <subfield code="u">http://www.opendefinition.org/licenses/cc-by</subfield>
  </datafield>
  <datafield tag="024" ind1=" " ind2=" ">
    <subfield code="a">10.1111/bph.12228</subfield>
    <subfield code="2">doi</subfield>
  </datafield>
  <datafield tag="245" ind1=" " ind2=" ">
    <subfield code="a">ORM-10103, a novel specific inhibitor of the Na+/Ca2+ exchanger, decreases early and delayed afterdepolarizations in the canine heart</subfield>
  </datafield>
  <datafield tag="100" ind1=" " ind2=" ">
    <subfield code="a">Jost, N.</subfield>
  </datafield>
  <datafield tag="909" ind1="C" ind2="O">
    <subfield code="o">oai:zenodo.org:14243</subfield>
    <subfield code="p">user-tubitak-destekli-proje-yayinlari</subfield>
  </datafield>
  <datafield tag="650" ind1="1" ind2="7">
    <subfield code="2">opendefinition.org</subfield>
    <subfield code="a">cc-by</subfield>
  </datafield>
  <datafield tag="260" ind1=" " ind2=" ">
    <subfield code="c">2013-01-01</subfield>
  </datafield>
  <datafield tag="856" ind1="4" ind2=" ">
    <subfield code="u">https://aperta.ulakbim.gov.trrecord/14243/files/bib-87677004-e1d5-4fd9-87dc-92341a9d302b.txt</subfield>
    <subfield code="z">md5:0a33593598f9cbe7dd0ac5f1f0dc195d</subfield>
    <subfield code="s">377</subfield>
  </datafield>
  <datafield tag="542" ind1=" " ind2=" ">
    <subfield code="l">open</subfield>
  </datafield>
  <controlfield tag="005">20210315081725.0</controlfield>
  <controlfield tag="001">14243</controlfield>
  <datafield tag="980" ind1=" " ind2=" ">
    <subfield code="a">publication</subfield>
    <subfield code="b">article</subfield>
  </datafield>
  <datafield tag="520" ind1=" " ind2=" ">
    <subfield code="a">Background and PurposeAt present there are no small molecule inhibitors that show strong selectivity for the Na+/Ca2+ exchanger (NCX). Hence, we studied the electrophysiological effects of acute administration of ORM-10103, a new NCX inhibitor, on the NCX and L-type Ca2+ currents and on the formation of early and delayed afterdepolarizations.</subfield>
  </datafield>
</record>